Trials / Completed
CompletedNCT02277548
A Pilot Study at a Single-Institution of Pregabalin in the Management of Mucositis Pain in Patients Undergoing Chemoradiation Therapy to the Head and Neck.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Abramson Cancer Center at Penn Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To assess the efficacy of pregabalin in the management of mucositis pain in patients receiving radiotherapy to the head and neck. Eligible study subjects will be enrolled among those being treated for oropharyngeal cancer with definitive chemotherapy and radiation therapy (photons) to the head and neck in the Department of Radiation Oncology at the University of Pennsylvania.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lyrica 300 mg | Lyrica 300 mg per day |
| DRUG | Placebo |
Timeline
- Start date
- 2014-05-01
- Primary completion
- 2018-04-01
- Completion
- 2018-04-01
- First posted
- 2014-10-29
- Last updated
- 2019-11-21
- Results posted
- 2019-11-21
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02277548. Inclusion in this directory is not an endorsement.